A Nonparametric Approach for Mild Cognitive Impairment to AD Conversion Prediction: Results on Longitudinal Data

The goal of this study is to introduce a nonparametric technique for predicting conversion from Mild Cognitive impairment (MCI)-to-Alzheimer's disease (AD). Progression of a slowly progressing disease such as AD benefits from the use of longitudinal data; however, research till now is limited due to the insufficient patient data and short follow-up time. A small dataset size invalidates the estimation of underlying disease progression model; hence, a supervised nonparametric method is proposed. While depicting a real-world setting, longitudinal data of three years are employed for training, whereas only the baseline visit's data is used for validation. The train set is preprocessed for extraction of two dense clusters representing the subjects who remain stable at MCI or progress to AD after three years of the baseline visit. Similarity between these clusters and the test point is calculated in Euclidean space. Multiple features from two modalities of biomarkers, i.e., neuropsychological measures (NM) and structural magnetic resonance imaging (MRI) morphometry are also analyzed. Due to the limited MCI dataset size (NM: 145, MRI: 52, NM+MRI: 29), leave-one-out cross validation setup is employed for performance evaluation. The algorithm performance is noted for both unimodal case and bimodal cases. Superior performance (accuracy: 89.66%, sensitivity: 87.50%, specificity: 92.31%, precision: 93.33%) is delivered by multivariate predictors. Three notable conclusions of this study are: 1) Longitudinal data are more powerful than the temporal data, 2) MRI is a better predictor of MCI-to-AD conversion than NM, and 3) multivariate predictors outperform single predictor models

[1]  Andrea C. Bozoki,et al.  Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification , 2016, PloS one.

[2]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[3]  Daoqiang Zhang,et al.  Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease , 2012, NeuroImage.

[4]  Dinggang Shen,et al.  A Robust Deep Model for Improved Classification of AD/MCI Patients , 2015, IEEE Journal of Biomedical and Health Informatics.

[5]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[6]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[7]  Daoqiang Zhang,et al.  Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers , 2012, PloS one.

[8]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[9]  C. Jack,et al.  Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance , 2012, Neurobiology of Aging.

[10]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[11]  James T Becker,et al.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment. , 2014, Journal of Alzheimer's disease : JAD.

[12]  T. Goldberg,et al.  Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. , 2011, Archives of general psychiatry.

[13]  Dinggang Shen,et al.  Joint estimation of multiple clinical variables of neurological diseases from imaging patterns , 2010, 2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[14]  Bruce Fischl,et al.  Highly accurate inverse consistent registration: A robust approach , 2010, NeuroImage.

[15]  Alzheimer’s Association 2015 Alzheimer's disease facts and figures , 2015, Alzheimer's & Dementia.

[16]  C. Davatzikos Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, Alzheimer's & Dementia.

[17]  Robert A. Dean,et al.  Florbetapir positron emission tomography and cerebrospinal fluid biomarkers , 2015, Alzheimer's & Dementia.

[18]  K. Lovblad,et al.  Individual Classification of Mild Cognitive Impairment Subtypes by Support Vector Machine Analysis of White Matter DTI , 2013, American Journal of Neuroradiology.

[19]  Yaakov Stern,et al.  Frequency and course of mild cognitive impairment in a multiethnic community , 2008, Annals of neurology.

[20]  Bai Ying Lei,et al.  Joint Learning of Multiple Longitudinal Prediction Models by Exploring Internal Relations , 2015, MLMI.

[21]  Anders M. Dale,et al.  A hybrid approach to the Skull Stripping problem in MRI , 2001, NeuroImage.

[22]  Jesse S. Jin,et al.  Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors , 2011, PloS one.

[23]  G. B. Frisoni,et al.  The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort , 2010, Neurobiology of Aging.

[24]  Juha Koikkalainen,et al.  Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort. , 2014, Journal of Alzheimer's disease : JAD.

[25]  Richard J. Kryscio,et al.  Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data , 2012, International journal of Alzheimer's disease.

[26]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[27]  W. M. van der Flier,et al.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.

[28]  Ying Wang,et al.  High-dimensional Pattern Regression Using Machine Learning: from Medical Images to Continuous Clinical Variables However, Support Vector Regression Has Some Disadvantages That Become Especially , 2022 .

[29]  A. Chincarini,et al.  Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study , 2014, NeuroImage: Clinical.

[30]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[31]  Ping Zhang,et al.  Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease , 2014, BMC Bioinformatics.

[32]  Shoab Ahmad Khan,et al.  Early Alzheimer's Disease Prediction in Machine Learning Setup: Empirical Analysis with Missing Value Computation , 2015, IDEAL.

[33]  Kun Hu,et al.  Multi-scale features extraction from baseline structure MRI for MCI patient classification and AD early diagnosis , 2016, Neurocomputing.

[34]  S. Resnick,et al.  Alzheimer's Disease Risk Assessment Using Large-Scale Machine Learning Methods , 2013, PLoS ONE.

[35]  Oscar López,et al.  A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. , 2013, Journal of Alzheimer's disease : JAD.

[36]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  Dinggang Shen,et al.  Deep Learning-Based Feature Representation for AD/MCI Classification , 2013, MICCAI.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[40]  S. Resnick,et al.  Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. , 2009, Brain : a journal of neurology.

[41]  J. Trojanowski,et al.  Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.

[42]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[43]  Heikki Huttunen,et al.  Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects , 2015, NeuroImage.